News | May 06, 2009

Neurosurgeon Wins BrainLab Award for Stereotactic Radiosurgery Study

Eric Nussbaum, M.D., chair of the National Brain Aneurysm Center based at St. Joseph's Hospital in St. Paul, Minn.

May 6, 2009 - Eric Nussbaum, M.D., chair of the National Brain Aneurysm Center based at St. Joseph's Hospital in St. Paul, Minn., will be presented with the 2009 BrainLAB Community Neurosurgeon Award at the American Association of Neurological Surgeons (AANS) annual conference in San Diego on Wednesday, May 6, 2009.

The BrainLAB Community Neurosurgery Award is presented to a neurosurgeon practicing in a nonacademic setting with the best abstract related to central nervous system tumors. Dr. Nussbaum is receiving the award for his presentation entitled "Long-Term Follow-Up, Results and Complications of the Middle Fossa Approach for Hearing Preservation in Acoustic Neuromas".

The study concluded that the use of stereotactic radiosurgery – which uses a laser to treat the brain tumor in a precise dose of targeted radiation – is the best option for preserving hearing in patients with acoustic neuromas. An acoustic neuroma is a noncancerous brain tumor located near the nerve which runs from the brain to the inner ear. Dr. Nussbaum’s research concluded that this approach was more beneficial to patients versus the middle fossa approach, a more invasive surgical technique in patients with small tumors and good preoperative hearing.

“Dr. Nussbaum is a remarkable surgeon and this award is a testament to that fact,” explained Sara Criger, chief executive officer of St. Joseph's Hospital, home of the National Brain Aneurysm Center. “His dedication to his patients is second-to-none and he is constantly researching new surgical techniques and efforts in an extremely complicated field. It is very gratifying to know his extensive efforts in brain tumor research are being rewarded on a national level.”

Dr. Nussbaum's clinical practice at the National Brain Aneurysm Center focuses exclusively on complex brain surgery including the treatment of brain aneurysms, vascular malformations, brain bypass procedures and skull base tumors. Dr. Nussbaum is among the top neurovascular surgeons in the country in terms of both volume and success rates.

For more information: and

Related Content

SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Overall survival of metastatic patients with SABR presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
News | Radiation Oncology | October 30, 2018
October 30, 2018 — In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggre
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment,...
CyberKnife System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
News | Stereotactic Body Radiation Therapy (SBRT) | September 27, 2018
Accuray Inc. announced that published data from two prospective, multi-center studies using differing protocols provide...
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
Age Impacts Post-treatment Mortality for Early-stage Lung Cancer Patients

Image courtesy of Henri Becquerel Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | January 24, 2018
A University of Colorado Cancer Center study published in the Journal of Clinical Oncology explores mortality in the...
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...